nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—Chloropyramine—Rosiglitazone—type 2 diabetes mellitus	0.151	1	CrCrCtD
Chlorpromazine—CALM1—type 2 diabetes mellitus	0.109	0.344	CbGaD
Chlorpromazine—ADRA2A—type 2 diabetes mellitus	0.0494	0.156	CbGaD
Chlorpromazine—HTR2C—type 2 diabetes mellitus	0.0455	0.144	CbGaD
Chlorpromazine—CYP2E1—type 2 diabetes mellitus	0.0361	0.114	CbGaD
Chlorpromazine—CYP1A2—type 2 diabetes mellitus	0.0343	0.108	CbGaD
Chlorpromazine—DRD5—Bromocriptine—type 2 diabetes mellitus	0.0251	0.0745	CbGbCtD
Chlorpromazine—CYP3A4—type 2 diabetes mellitus	0.0227	0.0717	CbGaD
Chlorpromazine—ALB—type 2 diabetes mellitus	0.0198	0.0625	CbGaD
Chlorpromazine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0184	0.0546	CbGbCtD
Chlorpromazine—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0179	0.0531	CbGbCtD
Chlorpromazine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0162	0.0479	CbGbCtD
Chlorpromazine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0144	0.0428	CbGbCtD
Chlorpromazine—BCHE—Ramipril—type 2 diabetes mellitus	0.0136	0.0404	CbGbCtD
Chlorpromazine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0133	0.0395	CbGbCtD
Chlorpromazine—ABCB11—Glyburide—type 2 diabetes mellitus	0.013	0.0385	CbGbCtD
Chlorpromazine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0128	0.0381	CbGbCtD
Chlorpromazine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0103	0.0305	CbGbCtD
Chlorpromazine—ALB—Gliclazide—type 2 diabetes mellitus	0.00979	0.029	CbGbCtD
Chlorpromazine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0094	0.0278	CbGbCtD
Chlorpromazine—ALB—Repaglinide—type 2 diabetes mellitus	0.0092	0.0273	CbGbCtD
Chlorpromazine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.00886	0.0262	CbGbCtD
Chlorpromazine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.00847	0.0251	CbGbCtD
Chlorpromazine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.00847	0.0251	CbGbCtD
Chlorpromazine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.00812	0.0241	CbGbCtD
Chlorpromazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.00781	0.0231	CbGbCtD
Chlorpromazine—ALB—Rosiglitazone—type 2 diabetes mellitus	0.00768	0.0228	CbGbCtD
Chlorpromazine—ALB—Valsartan—type 2 diabetes mellitus	0.00678	0.0201	CbGbCtD
Chlorpromazine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00676	0.02	CbGbCtD
Chlorpromazine—ALB—Nateglinide—type 2 diabetes mellitus	0.00631	0.0187	CbGbCtD
Chlorpromazine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00602	0.0178	CbGbCtD
Chlorpromazine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00459	0.0136	CbGbCtD
Chlorpromazine—SLC22A1—Metformin—type 2 diabetes mellitus	0.00441	0.0131	CbGbCtD
Chlorpromazine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00435	0.0129	CbGbCtD
Chlorpromazine—ALB—Glyburide—type 2 diabetes mellitus	0.00426	0.0126	CbGbCtD
Chlorpromazine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0041	0.0122	CbGbCtD
Chlorpromazine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00405	0.012	CbGbCtD
Chlorpromazine—ALB—Losartan—type 2 diabetes mellitus	0.0039	0.0115	CbGbCtD
Chlorpromazine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00379	0.0112	CbGbCtD
Chlorpromazine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00362	0.0107	CbGbCtD
Chlorpromazine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00361	0.0107	CbGbCtD
Chlorpromazine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00342	0.0101	CbGbCtD
Chlorpromazine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0033	0.00977	CbGbCtD
Chlorpromazine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00311	0.00921	CbGbCtD
Chlorpromazine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00299	0.00886	CbGbCtD
Chlorpromazine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00298	0.00883	CbGbCtD
Chlorpromazine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00288	0.00854	CbGbCtD
Chlorpromazine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00261	0.00773	CbGbCtD
Chlorpromazine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00233	0.00691	CbGbCtD
Chlorpromazine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00223	0.0066	CbGbCtD
Chlorpromazine—ABCB1—Losartan—type 2 diabetes mellitus	0.00204	0.00604	CbGbCtD
Chlorpromazine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00198	0.00586	CbGbCtD
Chlorpromazine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0019	0.00561	CbGbCtD
Chlorpromazine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0019	0.00561	CbGbCtD
Chlorpromazine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00179	0.00531	CbGbCtD
Chlorpromazine—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00134	0.0413	CbGeAlD
Chlorpromazine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00134	0.00396	CbGbCtD
Chlorpromazine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00131	0.0403	CbGeAlD
Chlorpromazine—HTR2A—arteriole—type 2 diabetes mellitus	0.00128	0.0394	CbGeAlD
Chlorpromazine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00122	0.00362	CbGbCtD
Chlorpromazine—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.000898	0.0277	CbGeAlD
Chlorpromazine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.000877	0.0271	CbGeAlD
Chlorpromazine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.000814	0.0251	CbGeAlD
Chlorpromazine—DRD1—nerve—type 2 diabetes mellitus	0.00079	0.0244	CbGeAlD
Chlorpromazine—SMPD1—islet of Langerhans—type 2 diabetes mellitus	0.000675	0.0208	CbGeAlD
Chlorpromazine—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.000651	0.0201	CbGeAlD
Chlorpromazine—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.000648	0.02	CbGeAlD
Chlorpromazine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.000633	0.0195	CbGeAlD
Chlorpromazine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000547	0.0169	CbGeAlD
Chlorpromazine—SMPD1—nephron tubule—type 2 diabetes mellitus	0.000544	0.0168	CbGeAlD
Chlorpromazine—CALM2—artery—type 2 diabetes mellitus	0.000512	0.0158	CbGeAlD
Chlorpromazine—CALM1—artery—type 2 diabetes mellitus	0.000509	0.0157	CbGeAlD
Chlorpromazine—CALM2—nerve—type 2 diabetes mellitus	0.000508	0.0157	CbGeAlD
Chlorpromazine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000506	0.0156	CbGeAlD
Chlorpromazine—CALM1—nerve—type 2 diabetes mellitus	0.000505	0.0156	CbGeAlD
Chlorpromazine—HTR7—artery—type 2 diabetes mellitus	0.000498	0.0154	CbGeAlD
Chlorpromazine—HTR7—nerve—type 2 diabetes mellitus	0.000494	0.0152	CbGeAlD
Chlorpromazine—SMPD1—cardiovascular system—type 2 diabetes mellitus	0.000488	0.0151	CbGeAlD
Chlorpromazine—SMPD1—kidney—type 2 diabetes mellitus	0.000478	0.0148	CbGeAlD
Chlorpromazine—DRD2—nerve—type 2 diabetes mellitus	0.000467	0.0144	CbGeAlD
Chlorpromazine—SMPD1—cortex of kidney—type 2 diabetes mellitus	0.000465	0.0144	CbGeAlD
Chlorpromazine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000464	0.0143	CbGeAlD
Chlorpromazine—CALM2—endothelium—type 2 diabetes mellitus	0.000432	0.0133	CbGeAlD
Chlorpromazine—SMPD1—adipose tissue—type 2 diabetes mellitus	0.000431	0.0133	CbGeAlD
Chlorpromazine—CALM1—endothelium—type 2 diabetes mellitus	0.00043	0.0133	CbGeAlD
Chlorpromazine—HTR7—endothelium—type 2 diabetes mellitus	0.00042	0.013	CbGeAlD
Chlorpromazine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000395	0.0122	CbGeAlD
Chlorpromazine—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.000313	0.00967	CbGeAlD
Chlorpromazine—HTR2A—artery—type 2 diabetes mellitus	0.00031	0.00958	CbGeAlD
Chlorpromazine—HTR2A—nerve—type 2 diabetes mellitus	0.000308	0.0095	CbGeAlD
Chlorpromazine—SMPD1—liver—type 2 diabetes mellitus	0.000302	0.00932	CbGeAlD
Chlorpromazine—ADRA1B—kidney—type 2 diabetes mellitus	0.00029	0.00897	CbGeAlD
Chlorpromazine—CALM3—retina—type 2 diabetes mellitus	0.000268	0.00827	CbGeAlD
Chlorpromazine—HTR2A—endothelium—type 2 diabetes mellitus	0.000262	0.00809	CbGeAlD
Chlorpromazine—CALM3—nephron tubule—type 2 diabetes mellitus	0.000252	0.00778	CbGeAlD
Chlorpromazine—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.000246	0.00759	CbGeAlD
Chlorpromazine—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.000245	0.00756	CbGeAlD
Chlorpromazine—ABCB11—liver—type 2 diabetes mellitus	0.000239	0.00738	CbGeAlD
Chlorpromazine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000223	0.00689	CbGeAlD
Chlorpromazine—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000223	0.00688	CbGeAlD
Chlorpromazine—CALM3—pancreas—type 2 diabetes mellitus	0.00022	0.0068	CbGeAlD
Chlorpromazine—CALM3—cortex of kidney—type 2 diabetes mellitus	0.000216	0.00666	CbGeAlD
Chlorpromazine—SLC22A1—kidney—type 2 diabetes mellitus	0.000214	0.00662	CbGeAlD
Chlorpromazine—CALM2—retina—type 2 diabetes mellitus	0.00021	0.00649	CbGeAlD
Chlorpromazine—CALM1—retina—type 2 diabetes mellitus	0.000209	0.00646	CbGeAlD
Chlorpromazine—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000203	0.00627	CbGeAlD
Chlorpromazine—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000202	0.00624	CbGeAlD
Chlorpromazine—CALM3—adipose tissue—type 2 diabetes mellitus	0.0002	0.00617	CbGeAlD
Chlorpromazine—CALM2—nephron tubule—type 2 diabetes mellitus	0.000198	0.00611	CbGeAlD
Chlorpromazine—CALM1—nephron tubule—type 2 diabetes mellitus	0.000197	0.00609	CbGeAlD
Chlorpromazine—DRD2—retina—type 2 diabetes mellitus	0.000193	0.00597	CbGeAlD
Chlorpromazine—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000193	0.00596	CbGeAlD
Chlorpromazine—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000192	0.00594	CbGeAlD
Chlorpromazine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000181	0.00559	CbGeAlD
Chlorpromazine—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000178	0.0055	CbGeAlD
Chlorpromazine—CALM2—cardiovascular system—type 2 diabetes mellitus	0.000178	0.00549	CbGeAlD
Chlorpromazine—CHRM3—kidney—type 2 diabetes mellitus	0.000178	0.00549	CbGeAlD
Chlorpromazine—CALM1—cardiovascular system—type 2 diabetes mellitus	0.000177	0.00547	CbGeAlD
Chlorpromazine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000175	0.00541	CbGeAlD
Chlorpromazine—CALM2—kidney—type 2 diabetes mellitus	0.000174	0.00537	CbGeAlD
Chlorpromazine—CALM1—kidney—type 2 diabetes mellitus	0.000173	0.00535	CbGeAlD
Chlorpromazine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000173	0.00534	CbGeAlD
Chlorpromazine—CALM2—pancreas—type 2 diabetes mellitus	0.000173	0.00534	CbGeAlD
Chlorpromazine—CALM1—pancreas—type 2 diabetes mellitus	0.000172	0.00531	CbGeAlD
Chlorpromazine—CALM2—cortex of kidney—type 2 diabetes mellitus	0.000169	0.00523	CbGeAlD
Chlorpromazine—HTR7—kidney—type 2 diabetes mellitus	0.000169	0.00522	CbGeAlD
Chlorpromazine—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000169	0.00521	CbGeAlD
Chlorpromazine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000167	0.00515	CbGeAlD
Chlorpromazine—Dermatitis exfoliative—Losartan—type 2 diabetes mellitus	0.000166	0.00218	CcSEcCtD
Chlorpromazine—Nervousness—Sitagliptin—type 2 diabetes mellitus	0.000166	0.00218	CcSEcCtD
Chlorpromazine—Gynaecomastia—Ramipril—type 2 diabetes mellitus	0.000165	0.00217	CcSEcCtD
Chlorpromazine—BCHE—nephron tubule—type 2 diabetes mellitus	0.000165	0.0051	CbGeAlD
Chlorpromazine—Asthma—Orlistat—type 2 diabetes mellitus	0.000165	0.00217	CcSEcCtD
Chlorpromazine—Influenza—Orlistat—type 2 diabetes mellitus	0.000165	0.00217	CcSEcCtD
Chlorpromazine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000164	0.00216	CcSEcCtD
Chlorpromazine—Syncope—Glipizide—type 2 diabetes mellitus	0.000164	0.00216	CcSEcCtD
Chlorpromazine—Leukopenia—Glipizide—type 2 diabetes mellitus	0.000164	0.00216	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Gliclazide—type 2 diabetes mellitus	0.000164	0.00216	CcSEcCtD
Chlorpromazine—Muscle spasms—Sitagliptin—type 2 diabetes mellitus	0.000164	0.00216	CcSEcCtD
Chlorpromazine—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.000162	0.00213	CcSEcCtD
Chlorpromazine—Loss of consciousness—Glipizide—type 2 diabetes mellitus	0.000161	0.00212	CcSEcCtD
Chlorpromazine—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000161	0.00497	CbGeAlD
Chlorpromazine—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.00016	0.00211	CcSEcCtD
Chlorpromazine—Tremor—Glimepiride—type 2 diabetes mellitus	0.00016	0.00211	CcSEcCtD
Chlorpromazine—CHRM3—adipose tissue—type 2 diabetes mellitus	0.00016	0.00495	CbGeAlD
Chlorpromazine—Hypoglycaemia—Losartan—type 2 diabetes mellitus	0.00016	0.00211	CcSEcCtD
Chlorpromazine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00016	0.0021	CcSEcCtD
Chlorpromazine—Jaundice—Gliclazide—type 2 diabetes mellitus	0.000158	0.00208	CcSEcCtD
Chlorpromazine—CALM2—adipose tissue—type 2 diabetes mellitus	0.000157	0.00484	CbGeAlD
Chlorpromazine—Angioedema—Glimepiride—type 2 diabetes mellitus	0.000156	0.00206	CcSEcCtD
Chlorpromazine—Visual impairment—Glyburide—type 2 diabetes mellitus	0.000156	0.00205	CcSEcCtD
Chlorpromazine—CALM1—adipose tissue—type 2 diabetes mellitus	0.000156	0.00482	CbGeAlD
Chlorpromazine—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00205	CcSEcCtD
Chlorpromazine—Constipation—Repaglinide—type 2 diabetes mellitus	0.000155	0.00203	CcSEcCtD
Chlorpromazine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000154	0.00202	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Valsartan—type 2 diabetes mellitus	0.000154	0.00202	CcSEcCtD
Chlorpromazine—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.000153	0.00201	CcSEcCtD
Chlorpromazine—Photosensitivity—Ramipril—type 2 diabetes mellitus	0.000153	0.00201	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Valsartan—type 2 diabetes mellitus	0.000152	0.00201	CcSEcCtD
Chlorpromazine—Influenza—Metformin—type 2 diabetes mellitus	0.000152	0.002	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Irbesartan—type 2 diabetes mellitus	0.000152	0.002	CcSEcCtD
Chlorpromazine—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.000151	0.00199	CcSEcCtD
Chlorpromazine—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.00015	0.00198	CcSEcCtD
Chlorpromazine—Nervousness—Bromocriptine—type 2 diabetes mellitus	0.00015	0.00197	CcSEcCtD
Chlorpromazine—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000149	0.00196	CcSEcCtD
Chlorpromazine—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000149	0.00196	CcSEcCtD
Chlorpromazine—Cough—Sitagliptin—type 2 diabetes mellitus	0.000149	0.00196	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Ramipril—type 2 diabetes mellitus	0.000148	0.00195	CcSEcCtD
Chlorpromazine—Muscle spasms—Bromocriptine—type 2 diabetes mellitus	0.000148	0.00195	CcSEcCtD
Chlorpromazine—BCHE—cardiovascular system—type 2 diabetes mellitus	0.000148	0.00458	CbGeAlD
Chlorpromazine—Convulsion—Glimepiride—type 2 diabetes mellitus	0.000148	0.00195	CcSEcCtD
Chlorpromazine—Shock—Glipizide—type 2 diabetes mellitus	0.000147	0.00194	CcSEcCtD
Chlorpromazine—Nasal congestion—Ramipril—type 2 diabetes mellitus	0.000147	0.00194	CcSEcCtD
Chlorpromazine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000147	0.00454	CbGeAlD
Chlorpromazine—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000146	0.00192	CcSEcCtD
Chlorpromazine—Asthma—Irbesartan—type 2 diabetes mellitus	0.000144	0.00189	CcSEcCtD
Chlorpromazine—Dysphagia—Irbesartan—type 2 diabetes mellitus	0.000144	0.00189	CcSEcCtD
Chlorpromazine—Influenza—Irbesartan—type 2 diabetes mellitus	0.000144	0.00189	CcSEcCtD
Chlorpromazine—Oedema peripheral—Gliclazide—type 2 diabetes mellitus	0.000143	0.00189	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000143	0.00189	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.000143	0.00188	CcSEcCtD
Chlorpromazine—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.000142	0.00187	CcSEcCtD
Chlorpromazine—Infection—Pioglitazone—type 2 diabetes mellitus	0.000142	0.00187	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Ramipril—type 2 diabetes mellitus	0.000142	0.00187	CcSEcCtD
Chlorpromazine—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.000142	0.00187	CcSEcCtD
Chlorpromazine—Visual impairment—Gliclazide—type 2 diabetes mellitus	0.00014	0.00184	CcSEcCtD
Chlorpromazine—CALM3—liver—type 2 diabetes mellitus	0.00014	0.00432	CbGeAlD
Chlorpromazine—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00014	0.00184	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000139	0.00183	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.000138	0.00182	CcSEcCtD
Chlorpromazine—Syncope—Bromocriptine—type 2 diabetes mellitus	0.000138	0.00182	CcSEcCtD
Chlorpromazine—Infection—Sitagliptin—type 2 diabetes mellitus	0.000138	0.00182	CcSEcCtD
Chlorpromazine—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000138	0.00182	CcSEcCtD
Chlorpromazine—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000138	0.00427	CbGeAlD
Chlorpromazine—Shock—Glimepiride—type 2 diabetes mellitus	0.000137	0.00181	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	0.000137	0.00181	CcSEcCtD
Chlorpromazine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000136	0.00179	CcSEcCtD
Chlorpromazine—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.000136	0.00178	CcSEcCtD
Chlorpromazine—Drowsiness—Metformin—type 2 diabetes mellitus	0.000136	0.00178	CcSEcCtD
Chlorpromazine—SLC22A1—liver—type 2 diabetes mellitus	0.000135	0.00418	CbGeAlD
Chlorpromazine—Insomnia—Glipizide—type 2 diabetes mellitus	0.000135	0.00178	CcSEcCtD
Chlorpromazine—Influenza—Losartan—type 2 diabetes mellitus	0.000135	0.00178	CcSEcCtD
Chlorpromazine—Eosinophilia—Losartan—type 2 diabetes mellitus	0.000134	0.00176	CcSEcCtD
Chlorpromazine—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000134	0.00176	CcSEcCtD
Chlorpromazine—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000133	0.00175	CcSEcCtD
Chlorpromazine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000133	0.00175	CcSEcCtD
Chlorpromazine—Somnolence—Glipizide—type 2 diabetes mellitus	0.000133	0.00175	CcSEcCtD
Chlorpromazine—Tremor—Glyburide—type 2 diabetes mellitus	0.000132	0.00174	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.000131	0.00172	CcSEcCtD
Chlorpromazine—BCHE—adipose tissue—type 2 diabetes mellitus	0.000131	0.00404	CbGeAlD
Chlorpromazine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00013	0.00172	CcSEcCtD
Chlorpromazine—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.00013	0.00171	CcSEcCtD
Chlorpromazine—ALB—liver—type 2 diabetes mellitus	0.00013	0.004	CbGeAlD
Chlorpromazine—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.00013	0.00171	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.000129	0.0017	CcSEcCtD
Chlorpromazine—Angioedema—Glyburide—type 2 diabetes mellitus	0.000129	0.0017	CcSEcCtD
Chlorpromazine—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000128	0.00169	CcSEcCtD
Chlorpromazine—Constipation—Glipizide—type 2 diabetes mellitus	0.000128	0.00168	CcSEcCtD
Chlorpromazine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000128	0.00168	CcSEcCtD
Chlorpromazine—HTR2A—retina—type 2 diabetes mellitus	0.000127	0.00394	CbGeAlD
Chlorpromazine—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000126	0.00166	CcSEcCtD
Chlorpromazine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000126	0.00166	CcSEcCtD
Chlorpromazine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000126	0.00166	CcSEcCtD
Chlorpromazine—Infection—Bromocriptine—type 2 diabetes mellitus	0.000125	0.00165	CcSEcCtD
Chlorpromazine—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000125	0.00164	CcSEcCtD
Chlorpromazine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000124	0.00164	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.000124	0.00164	CcSEcCtD
Chlorpromazine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000124	0.00163	CcSEcCtD
Chlorpromazine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000124	0.00383	CbGeAlD
Chlorpromazine—Shock—Bromocriptine—type 2 diabetes mellitus	0.000124	0.00163	CcSEcCtD
Chlorpromazine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000124	0.00163	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000123	0.00162	CcSEcCtD
Chlorpromazine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000123	0.00381	CbGeAlD
Chlorpromazine—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000123	0.00162	CcSEcCtD
Chlorpromazine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000123	0.00162	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000122	0.00161	CcSEcCtD
Chlorpromazine—Convulsion—Glyburide—type 2 diabetes mellitus	0.000122	0.00161	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000122	0.0016	CcSEcCtD
Chlorpromazine—CYP2E1—kidney—type 2 diabetes mellitus	0.000121	0.00375	CbGeAlD
Chlorpromazine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000121	0.00373	CbGeAlD
Chlorpromazine—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.00012	0.00158	CcSEcCtD
Chlorpromazine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000119	0.00157	CcSEcCtD
Chlorpromazine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000119	0.00157	CcSEcCtD
Chlorpromazine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000119	0.00156	CcSEcCtD
Chlorpromazine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000118	0.00365	CbGeAlD
Chlorpromazine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000118	0.00155	CcSEcCtD
Chlorpromazine—Jaundice—Losartan—type 2 diabetes mellitus	0.000117	0.00154	CcSEcCtD
Chlorpromazine—Asthma—Ramipril—type 2 diabetes mellitus	0.000116	0.00152	CcSEcCtD
Chlorpromazine—Dysphagia—Ramipril—type 2 diabetes mellitus	0.000116	0.00152	CcSEcCtD
Chlorpromazine—Influenza—Ramipril—type 2 diabetes mellitus	0.000116	0.00152	CcSEcCtD
Chlorpromazine—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000116	0.00152	CcSEcCtD
Chlorpromazine—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000115	0.00151	CcSEcCtD
Chlorpromazine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000114	0.0015	CcSEcCtD
Chlorpromazine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000114	0.00352	CbGeAlD
Chlorpromazine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000113	0.00149	CcSEcCtD
Chlorpromazine—Shock—Glyburide—type 2 diabetes mellitus	0.000113	0.00149	CcSEcCtD
Chlorpromazine—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000113	0.00149	CcSEcCtD
Chlorpromazine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000113	0.00149	CcSEcCtD
Chlorpromazine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000112	0.00148	CcSEcCtD
Chlorpromazine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000112	0.00148	CcSEcCtD
Chlorpromazine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000112	0.00147	CcSEcCtD
Chlorpromazine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000112	0.00147	CcSEcCtD
Chlorpromazine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000112	0.00345	CbGeAlD
Chlorpromazine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000111	0.00146	CcSEcCtD
Chlorpromazine—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000111	0.00146	CcSEcCtD
Chlorpromazine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000111	0.00145	CcSEcCtD
Chlorpromazine—Cough—Gliclazide—type 2 diabetes mellitus	0.000111	0.00145	CcSEcCtD
Chlorpromazine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00011	0.00145	CcSEcCtD
Chlorpromazine—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.00011	0.00145	CcSEcCtD
Chlorpromazine—CALM2—liver—type 2 diabetes mellitus	0.00011	0.0034	CbGeAlD
Chlorpromazine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00011	0.00144	CcSEcCtD
Chlorpromazine—CALM1—liver—type 2 diabetes mellitus	0.000109	0.00338	CbGeAlD
Chlorpromazine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000108	0.00333	CbGeAlD
Chlorpromazine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000108	0.00142	CcSEcCtD
Chlorpromazine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000108	0.00142	CcSEcCtD
Chlorpromazine—HTR7—liver—type 2 diabetes mellitus	0.000107	0.0033	CbGeAlD
Chlorpromazine—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000107	0.0014	CcSEcCtD
Chlorpromazine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000106	0.0014	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000106	0.00139	CcSEcCtD
Chlorpromazine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000106	0.00139	CcSEcCtD
Chlorpromazine—HTR2A—kidney—type 2 diabetes mellitus	0.000105	0.00326	CbGeAlD
Chlorpromazine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000105	0.00139	CcSEcCtD
Chlorpromazine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000105	0.00138	CcSEcCtD
Chlorpromazine—Syncope—Valsartan—type 2 diabetes mellitus	0.000104	0.00137	CcSEcCtD
Chlorpromazine—ADRA1A—liver—type 2 diabetes mellitus	0.000103	0.00319	CbGeAlD
Chlorpromazine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000103	0.00135	CcSEcCtD
Chlorpromazine—Infection—Gliclazide—type 2 diabetes mellitus	0.000103	0.00135	CcSEcCtD
Chlorpromazine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000103	0.00135	CcSEcCtD
Chlorpromazine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000103	0.00135	CcSEcCtD
Chlorpromazine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000102	0.00135	CcSEcCtD
Chlorpromazine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000102	0.00134	CcSEcCtD
Chlorpromazine—Cough—Valsartan—type 2 diabetes mellitus	0.000102	0.00134	CcSEcCtD
Chlorpromazine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000101	0.00133	CcSEcCtD
Chlorpromazine—Jaundice—Ramipril—type 2 diabetes mellitus	0.000101	0.00132	CcSEcCtD
Chlorpromazine—Cough—Orlistat—type 2 diabetes mellitus	0.0001	0.00132	CcSEcCtD
Chlorpromazine—Fluphenazine—CALM1—type 2 diabetes mellitus	0.0001	0.0414	CrCbGaD
Chlorpromazine—Convulsion—Orlistat—type 2 diabetes mellitus	9.96e-05	0.00131	CcSEcCtD
Chlorpromazine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	9.96e-05	0.00131	CcSEcCtD
Chlorpromazine—Tremor—Metformin—type 2 diabetes mellitus	9.93e-05	0.00131	CcSEcCtD
Chlorpromazine—Dizziness—Glipizide—type 2 diabetes mellitus	9.89e-05	0.0013	CcSEcCtD
Chlorpromazine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	9.77e-05	0.00302	CbGeAlD
Chlorpromazine—CYP3A4—kidney—type 2 diabetes mellitus	9.77e-05	0.00302	CbGeAlD
Chlorpromazine—Nervousness—Irbesartan—type 2 diabetes mellitus	9.71e-05	0.00128	CcSEcCtD
Chlorpromazine—Dry mouth—Valsartan—type 2 diabetes mellitus	9.69e-05	0.00127	CcSEcCtD
Chlorpromazine—Hypotension—Gliclazide—type 2 diabetes mellitus	9.66e-05	0.00127	CcSEcCtD
Chlorpromazine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	9.64e-05	0.00127	CcSEcCtD
Chlorpromazine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	9.62e-05	0.00126	CcSEcCtD
Chlorpromazine—CYP2D6—kidney—type 2 diabetes mellitus	9.61e-05	0.00297	CbGeAlD
Chlorpromazine—Dry mouth—Orlistat—type 2 diabetes mellitus	9.58e-05	0.00126	CcSEcCtD
Chlorpromazine—Syncope—Metformin—type 2 diabetes mellitus	9.5e-05	0.00125	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	9.5e-05	0.00125	CcSEcCtD
Chlorpromazine—Dizziness—Pioglitazone—type 2 diabetes mellitus	9.48e-05	0.00125	CcSEcCtD
Chlorpromazine—Infection—Valsartan—type 2 diabetes mellitus	9.44e-05	0.00124	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	9.39e-05	0.00123	CcSEcCtD
Chlorpromazine—Tremor—Irbesartan—type 2 diabetes mellitus	9.37e-05	0.00123	CcSEcCtD
Chlorpromazine—Insomnia—Gliclazide—type 2 diabetes mellitus	9.35e-05	0.00123	CcSEcCtD
Chlorpromazine—Shock—Valsartan—type 2 diabetes mellitus	9.34e-05	0.00123	CcSEcCtD
Chlorpromazine—Infection—Orlistat—type 2 diabetes mellitus	9.32e-05	0.00123	CcSEcCtD
Chlorpromazine—Loss of consciousness—Metformin—type 2 diabetes mellitus	9.31e-05	0.00123	CcSEcCtD
Chlorpromazine—Dizziness—Glimepiride—type 2 diabetes mellitus	9.23e-05	0.00121	CcSEcCtD
Chlorpromazine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	9.22e-05	0.00121	CcSEcCtD
Chlorpromazine—Dizziness—Sitagliptin—type 2 diabetes mellitus	9.2e-05	0.00121	CcSEcCtD
Chlorpromazine—Somnolence—Gliclazide—type 2 diabetes mellitus	9.19e-05	0.00121	CcSEcCtD
Chlorpromazine—BCHE—liver—type 2 diabetes mellitus	9.17e-05	0.00283	CbGeAlD
Chlorpromazine—Nervousness—Losartan—type 2 diabetes mellitus	9.14e-05	0.0012	CcSEcCtD
Chlorpromazine—Angioedema—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.0012	CcSEcCtD
Chlorpromazine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	9.13e-05	0.0012	CcSEcCtD
Chlorpromazine—Muscle spasms—Losartan—type 2 diabetes mellitus	9.05e-05	0.00119	CcSEcCtD
Chlorpromazine—Syncope—Irbesartan—type 2 diabetes mellitus	8.97e-05	0.00118	CcSEcCtD
Chlorpromazine—Leukopenia—Irbesartan—type 2 diabetes mellitus	8.95e-05	0.00118	CcSEcCtD
Chlorpromazine—Visual impairment—Ramipril—type 2 diabetes mellitus	8.93e-05	0.00118	CcSEcCtD
Chlorpromazine—Hypotension—Valsartan—type 2 diabetes mellitus	8.88e-05	0.00117	CcSEcCtD
Chlorpromazine—Constipation—Gliclazide—type 2 diabetes mellitus	8.84e-05	0.00116	CcSEcCtD
Chlorpromazine—Tremor—Losartan—type 2 diabetes mellitus	8.82e-05	0.00116	CcSEcCtD
Chlorpromazine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	8.79e-05	0.00116	CcSEcCtD
Chlorpromazine—Cough—Irbesartan—type 2 diabetes mellitus	8.73e-05	0.00115	CcSEcCtD
Chlorpromazine—Angioedema—Losartan—type 2 diabetes mellitus	8.6e-05	0.00113	CcSEcCtD
Chlorpromazine—Infection—Metformin—type 2 diabetes mellitus	8.59e-05	0.00113	CcSEcCtD
Chlorpromazine—Insomnia—Valsartan—type 2 diabetes mellitus	8.59e-05	0.00113	CcSEcCtD
Chlorpromazine—CYP1A2—liver—type 2 diabetes mellitus	8.53e-05	0.00263	CbGeAlD
Chlorpromazine—Shock—Metformin—type 2 diabetes mellitus	8.51e-05	0.00112	CcSEcCtD
Chlorpromazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	8.49e-05	0.0351	CrCbGaD
Chlorpromazine—Insomnia—Orlistat—type 2 diabetes mellitus	8.49e-05	0.00112	CcSEcCtD
Chlorpromazine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.48e-05	0.00112	CcSEcCtD
Chlorpromazine—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.47e-05	0.00111	CcSEcCtD
Chlorpromazine—Somnolence—Valsartan—type 2 diabetes mellitus	8.44e-05	0.00111	CcSEcCtD
Chlorpromazine—Syncope—Losartan—type 2 diabetes mellitus	8.44e-05	0.00111	CcSEcCtD
Chlorpromazine—Leukopenia—Losartan—type 2 diabetes mellitus	8.43e-05	0.00111	CcSEcCtD
Chlorpromazine—ABCB1—retina—type 2 diabetes mellitus	8.35e-05	0.00258	CbGeAlD
Chlorpromazine—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.33e-05	0.0011	CcSEcCtD
Chlorpromazine—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.33e-05	0.0011	CcSEcCtD
Chlorpromazine—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.27e-05	0.00109	CcSEcCtD
Chlorpromazine—Cough—Losartan—type 2 diabetes mellitus	8.21e-05	0.00108	CcSEcCtD
Chlorpromazine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.17e-05	0.00108	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.16e-05	0.00107	CcSEcCtD
Chlorpromazine—Constipation—Valsartan—type 2 diabetes mellitus	8.12e-05	0.00107	CcSEcCtD
Chlorpromazine—Promethazine—CALM1—type 2 diabetes mellitus	8.12e-05	0.0335	CrCbGaD
Chlorpromazine—Infection—Irbesartan—type 2 diabetes mellitus	8.11e-05	0.00107	CcSEcCtD
Chlorpromazine—Hypotension—Metformin—type 2 diabetes mellitus	8.08e-05	0.00106	CcSEcCtD
Chlorpromazine—Shock—Irbesartan—type 2 diabetes mellitus	8.03e-05	0.00106	CcSEcCtD
Chlorpromazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	8.01e-05	0.0331	CrCbGaD
Chlorpromazine—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.00105	CcSEcCtD
Chlorpromazine—Perphenazine—CALM1—type 2 diabetes mellitus	7.92e-05	0.0327	CrCbGaD
Chlorpromazine—ABCB1—nephron tubule—type 2 diabetes mellitus	7.87e-05	0.00243	CbGeAlD
Chlorpromazine—Nervousness—Ramipril—type 2 diabetes mellitus	7.84e-05	0.00103	CcSEcCtD
Chlorpromazine—Dry mouth—Losartan—type 2 diabetes mellitus	7.84e-05	0.00103	CcSEcCtD
Chlorpromazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	7.82e-05	0.0323	CrCbGaD
Chlorpromazine—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.76e-05	0.00102	CcSEcCtD
Chlorpromazine—Dyspnoea—Metformin—type 2 diabetes mellitus	7.71e-05	0.00101	CcSEcCtD
Chlorpromazine—Somnolence—Metformin—type 2 diabetes mellitus	7.69e-05	0.00101	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.68e-05	0.00101	CcSEcCtD
Chlorpromazine—CYP2E1—liver—type 2 diabetes mellitus	7.67e-05	0.00237	CbGeAlD
Chlorpromazine—Infection—Losartan—type 2 diabetes mellitus	7.63e-05	0.001	CcSEcCtD
Chlorpromazine—Hypotension—Irbesartan—type 2 diabetes mellitus	7.63e-05	0.001	CcSEcCtD
Chlorpromazine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.62e-05	0.001	CcSEcCtD
Chlorpromazine—Tremor—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000995	CcSEcCtD
Chlorpromazine—Shock—Losartan—type 2 diabetes mellitus	7.56e-05	0.000994	CcSEcCtD
Chlorpromazine—Tachycardia—Losartan—type 2 diabetes mellitus	7.5e-05	0.000986	CcSEcCtD
Chlorpromazine—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.42e-05	0.000976	CcSEcCtD
Chlorpromazine—Constipation—Metformin—type 2 diabetes mellitus	7.4e-05	0.000973	CcSEcCtD
Chlorpromazine—Angioedema—Ramipril—type 2 diabetes mellitus	7.37e-05	0.00097	CcSEcCtD
Chlorpromazine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000957	CcSEcCtD
Chlorpromazine—Somnolence—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000955	CcSEcCtD
Chlorpromazine—Syncope—Ramipril—type 2 diabetes mellitus	7.24e-05	0.000952	CcSEcCtD
Chlorpromazine—Leukopenia—Ramipril—type 2 diabetes mellitus	7.22e-05	0.00095	CcSEcCtD
Chlorpromazine—Hypotension—Losartan—type 2 diabetes mellitus	7.18e-05	0.000944	CcSEcCtD
Chlorpromazine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000933	CcSEcCtD
Chlorpromazine—ABCB1—cardiovascular system—type 2 diabetes mellitus	7.07e-05	0.00218	CbGeAlD
Chlorpromazine—Cough—Ramipril—type 2 diabetes mellitus	7.04e-05	0.000926	CcSEcCtD
Chlorpromazine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7e-05	0.000921	CcSEcCtD
Chlorpromazine—Convulsion—Ramipril—type 2 diabetes mellitus	6.99e-05	0.00092	CcSEcCtD
Chlorpromazine—Constipation—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000918	CcSEcCtD
Chlorpromazine—Insomnia—Losartan—type 2 diabetes mellitus	6.95e-05	0.000914	CcSEcCtD
Chlorpromazine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.91e-05	0.00091	CcSEcCtD
Chlorpromazine—ABCB1—kidney—type 2 diabetes mellitus	6.91e-05	0.00213	CbGeAlD
Chlorpromazine—ABCB1—pancreas—type 2 diabetes mellitus	6.87e-05	0.00212	CbGeAlD
Chlorpromazine—Dyspnoea—Losartan—type 2 diabetes mellitus	6.85e-05	0.000901	CcSEcCtD
Chlorpromazine—Dizziness—Gliclazide—type 2 diabetes mellitus	6.84e-05	0.000899	CcSEcCtD
Chlorpromazine—Somnolence—Losartan—type 2 diabetes mellitus	6.83e-05	0.000898	CcSEcCtD
Chlorpromazine—ABCB1—cortex of kidney—type 2 diabetes mellitus	6.73e-05	0.00208	CbGeAlD
Chlorpromazine—Dry mouth—Ramipril—type 2 diabetes mellitus	6.72e-05	0.000884	CcSEcCtD
Chlorpromazine—HTR2A—liver—type 2 diabetes mellitus	6.67e-05	0.00206	CbGeAlD
Chlorpromazine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.59e-05	0.000866	CcSEcCtD
Chlorpromazine—Constipation—Losartan—type 2 diabetes mellitus	6.57e-05	0.000864	CcSEcCtD
Chlorpromazine—Shock—Ramipril—type 2 diabetes mellitus	6.48e-05	0.000852	CcSEcCtD
Chlorpromazine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.000849	CcSEcCtD
Chlorpromazine—Tachycardia—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000846	CcSEcCtD
Chlorpromazine—Dizziness—Valsartan—type 2 diabetes mellitus	6.28e-05	0.000826	CcSEcCtD
Chlorpromazine—ABCB1—adipose tissue—type 2 diabetes mellitus	6.23e-05	0.00192	CbGeAlD
Chlorpromazine—Dizziness—Orlistat—type 2 diabetes mellitus	6.21e-05	0.000816	CcSEcCtD
Chlorpromazine—CYP3A4—liver—type 2 diabetes mellitus	6.17e-05	0.00191	CbGeAlD
Chlorpromazine—Hypotension—Ramipril—type 2 diabetes mellitus	6.15e-05	0.00081	CcSEcCtD
Chlorpromazine—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	6.08e-05	0.0251	CrCbGaD
Chlorpromazine—CYP2D6—liver—type 2 diabetes mellitus	6.07e-05	0.00188	CbGeAlD
Chlorpromazine—Body temperature increased—Losartan—type 2 diabetes mellitus	6.07e-05	0.000799	CcSEcCtD
Chlorpromazine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000791	CcSEcCtD
Chlorpromazine—Insomnia—Ramipril—type 2 diabetes mellitus	5.96e-05	0.000784	CcSEcCtD
Chlorpromazine—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000773	CcSEcCtD
Chlorpromazine—Somnolence—Ramipril—type 2 diabetes mellitus	5.86e-05	0.00077	CcSEcCtD
Chlorpromazine—Dizziness—Metformin—type 2 diabetes mellitus	5.72e-05	0.000752	CcSEcCtD
Chlorpromazine—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.66e-05	0.000745	CcSEcCtD
Chlorpromazine—Constipation—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000741	CcSEcCtD
Chlorpromazine—Dizziness—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.00071	CcSEcCtD
Chlorpromazine—Thiothixene—ADRA2A—type 2 diabetes mellitus	5.25e-05	0.0217	CrCbGaD
Chlorpromazine—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000685	CcSEcCtD
Chlorpromazine—Dizziness—Losartan—type 2 diabetes mellitus	5.08e-05	0.000668	CcSEcCtD
Chlorpromazine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000638	CcSEcCtD
Chlorpromazine—Thiothixene—HTR2C—type 2 diabetes mellitus	4.83e-05	0.0199	CrCbGaD
Chlorpromazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	4.77e-05	0.0197	CrCbGaD
Chlorpromazine—Carbinoxamine—CYP2E1—type 2 diabetes mellitus	4.74e-05	0.0196	CrCbGaD
Chlorpromazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	4.62e-05	0.0191	CrCbGaD
Chlorpromazine—Fluphenazine—ADRA2A—type 2 diabetes mellitus	4.53e-05	0.0187	CrCbGaD
Chlorpromazine—ABCB1—liver—type 2 diabetes mellitus	4.37e-05	0.00135	CbGeAlD
Chlorpromazine—Dizziness—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000573	CcSEcCtD
Chlorpromazine—Fluphenazine—HTR2C—type 2 diabetes mellitus	4.17e-05	0.0172	CrCbGaD
Chlorpromazine—Clomipramine—ADRA2A—type 2 diabetes mellitus	4.15e-05	0.0171	CrCbGaD
Chlorpromazine—Propiomazine—HTR2C—type 2 diabetes mellitus	4.01e-05	0.0166	CrCbGaD
Chlorpromazine—Alimemazine—CYP3A4—type 2 diabetes mellitus	3.94e-05	0.0163	CrCbGaD
Chlorpromazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	3.91e-05	0.0161	CrCbGaD
Chlorpromazine—Clomipramine—HTR2C—type 2 diabetes mellitus	3.82e-05	0.0158	CrCbGaD
Chlorpromazine—Trimipramine—ADRA2A—type 2 diabetes mellitus	3.82e-05	0.0158	CrCbGaD
Chlorpromazine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	3.8e-05	0.0157	CrCbGaD
Chlorpromazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	3.73e-05	0.0154	CrCbGaD
Chlorpromazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	3.64e-05	0.015	CrCbGaD
Chlorpromazine—Thiothixene—CYP1A2—type 2 diabetes mellitus	3.64e-05	0.015	CrCbGaD
Chlorpromazine—Thioridazine—HTR2C—type 2 diabetes mellitus	3.6e-05	0.0148	CrCbGaD
Chlorpromazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	3.58e-05	0.0148	CrCbGaD
Chlorpromazine—Trimipramine—HTR2C—type 2 diabetes mellitus	3.51e-05	0.0145	CrCbGaD
Chlorpromazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	3.43e-05	0.0142	CrCbGaD
Chlorpromazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	3.39e-05	0.014	CrCbGaD
Chlorpromazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	3.34e-05	0.0138	CrCbGaD
Chlorpromazine—Fluphenazine—CYP2E1—type 2 diabetes mellitus	3.31e-05	0.0137	CrCbGaD
Chlorpromazine—Perphenazine—HTR2C—type 2 diabetes mellitus	3.3e-05	0.0136	CrCbGaD
Chlorpromazine—Promazine—ADRA2A—type 2 diabetes mellitus	3.23e-05	0.0133	CrCbGaD
Chlorpromazine—Fluphenazine—CYP1A2—type 2 diabetes mellitus	3.15e-05	0.013	CrCbGaD
Chlorpromazine—Desipramine—HTR2C—type 2 diabetes mellitus	3.07e-05	0.0127	CrCbGaD
Chlorpromazine—Diltiazem—CYP3A4—type 2 diabetes mellitus	3.04e-05	0.0126	CrCbGaD
Chlorpromazine—Carbinoxamine—CYP3A4—type 2 diabetes mellitus	2.99e-05	0.0123	CrCbGaD
Chlorpromazine—Promazine—HTR2C—type 2 diabetes mellitus	2.98e-05	0.0123	CrCbGaD
Chlorpromazine—Clomipramine—CYP1A2—type 2 diabetes mellitus	2.88e-05	0.0119	CrCbGaD
Chlorpromazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	2.85e-05	0.0118	CrCbGaD
Chlorpromazine—Flurazepam—CYP2E1—type 2 diabetes mellitus	2.81e-05	0.0116	CrCbGaD
Chlorpromazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	2.72e-05	0.0112	CrCbGaD
Chlorpromazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	2.71e-05	0.0112	CrCbGaD
Chlorpromazine—Imipramine—HTR2C—type 2 diabetes mellitus	2.6e-05	0.0108	CrCbGaD
Chlorpromazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	2.59e-05	0.0107	CrCbGaD
Chlorpromazine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	2.54e-05	0.0105	CrCbGaD
Chlorpromazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	2.52e-05	0.0104	CrCbGaD
Chlorpromazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	2.49e-05	0.0103	CrCbGaD
Chlorpromazine—Desipramine—CYP2E1—type 2 diabetes mellitus	2.44e-05	0.0101	CrCbGaD
Chlorpromazine—Clobazam—CYP3A4—type 2 diabetes mellitus	2.41e-05	0.00996	CrCbGaD
Chlorpromazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	2.41e-05	0.00996	CrCbGaD
Chlorpromazine—Desipramine—CYP1A2—type 2 diabetes mellitus	2.32e-05	0.00957	CrCbGaD
Chlorpromazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	2.31e-05	0.00952	CrCbGaD
Chlorpromazine—Promazine—CYP1A2—type 2 diabetes mellitus	2.24e-05	0.00927	CrCbGaD
Chlorpromazine—Acepromazine—ALB—type 2 diabetes mellitus	2.19e-05	0.00904	CrCbGaD
Chlorpromazine—Thioproperazine—ALB—type 2 diabetes mellitus	2.14e-05	0.00883	CrCbGaD
Chlorpromazine—Pipotiazine—ALB—type 2 diabetes mellitus	2.1e-05	0.00869	CrCbGaD
Chlorpromazine—Thiothixene—ALB—type 2 diabetes mellitus	2.1e-05	0.00869	CrCbGaD
Chlorpromazine—Imipramine—CYP2E1—type 2 diabetes mellitus	2.07e-05	0.00853	CrCbGaD
Chlorpromazine—Adinazolam—CYP3A4—type 2 diabetes mellitus	1.97e-05	0.00812	CrCbGaD
Chlorpromazine—Imipramine—CYP1A2—type 2 diabetes mellitus	1.97e-05	0.00812	CrCbGaD
Chlorpromazine—Clomipramine—CYP3A4—type 2 diabetes mellitus	1.91e-05	0.00787	CrCbGaD
Chlorpromazine—Flurazepam—CYP3A4—type 2 diabetes mellitus	1.77e-05	0.00732	CrCbGaD
Chlorpromazine—Trimipramine—CYP3A4—type 2 diabetes mellitus	1.75e-05	0.00724	CrCbGaD
Chlorpromazine—Clomipramine—ALB—type 2 diabetes mellitus	1.66e-05	0.00687	CrCbGaD
Chlorpromazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	1.65e-05	0.00681	CrCbGaD
Chlorpromazine—Desipramine—CYP3A4—type 2 diabetes mellitus	1.53e-05	0.00633	CrCbGaD
Chlorpromazine—Promazine—CYP3A4—type 2 diabetes mellitus	1.49e-05	0.00614	CrCbGaD
Chlorpromazine—Imipramine—CYP3A4—type 2 diabetes mellitus	1.3e-05	0.00537	CrCbGaD
Chlorpromazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.22e-07	7.42e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.21e-07	7.42e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	6.21e-07	7.41e-06	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	6.21e-07	7.41e-06	CbGpPWpGaD
Chlorpromazine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.2e-07	7.4e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.18e-07	7.38e-06	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	6.18e-07	7.37e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.16e-07	7.35e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.16e-07	7.35e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—SRC—type 2 diabetes mellitus	6.15e-07	7.34e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—SRC—type 2 diabetes mellitus	6.15e-07	7.34e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.14e-07	7.33e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	6.13e-07	7.31e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.12e-07	7.31e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.12e-07	7.3e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.1e-07	7.29e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.1e-07	7.29e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.1e-07	7.28e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.1e-07	7.28e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.1e-07	7.28e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.08e-07	7.26e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.08e-07	7.26e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.06e-07	7.24e-06	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.05e-07	7.22e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.04e-07	7.22e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—EGFR—type 2 diabetes mellitus	6.04e-07	7.21e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.03e-07	7.2e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.02e-07	7.19e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.02e-07	7.19e-06	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.01e-07	7.18e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	6e-07	7.17e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.99e-07	7.15e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	5.98e-07	7.14e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	5.93e-07	7.08e-06	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	5.91e-07	7.06e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.91e-07	7.06e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.88e-07	7.02e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.88e-07	7.02e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.86e-07	7e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.85e-07	6.99e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.85e-07	6.98e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—EGFR—type 2 diabetes mellitus	5.84e-07	6.97e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—EGFR—type 2 diabetes mellitus	5.84e-07	6.97e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	5.83e-07	6.96e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.82e-07	6.95e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.82e-07	6.95e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.82e-07	6.95e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.82e-07	6.95e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.82e-07	6.95e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	5.81e-07	6.94e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.8e-07	6.93e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.79e-07	6.91e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.77e-07	6.89e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.77e-07	6.89e-06	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.76e-07	6.87e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.76e-07	6.87e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	5.75e-07	6.86e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.74e-07	6.86e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.73e-07	6.85e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.72e-07	6.83e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.71e-07	6.82e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.71e-07	6.81e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	5.7e-07	6.81e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.7e-07	6.8e-06	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	5.69e-07	6.8e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—TGFB1—type 2 diabetes mellitus	5.68e-07	6.79e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	5.66e-07	6.76e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.65e-07	6.75e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.65e-07	6.75e-06	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	5.65e-07	6.75e-06	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	5.64e-07	6.74e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.64e-07	6.74e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.64e-07	6.73e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.63e-07	6.72e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.61e-07	6.7e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.6e-07	6.69e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.6e-07	6.69e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.59e-07	6.68e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—EGFR—type 2 diabetes mellitus	5.57e-07	6.65e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.56e-07	6.64e-06	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.55e-07	6.63e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.54e-07	6.61e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.52e-07	6.6e-06	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.52e-07	6.59e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—TGFB1—type 2 diabetes mellitus	5.5e-07	6.56e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—TGFB1—type 2 diabetes mellitus	5.5e-07	6.56e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.48e-07	6.54e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.48e-07	6.54e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.45e-07	6.51e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	5.45e-07	6.51e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.45e-07	6.51e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	5.45e-07	6.51e-06	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.44e-07	6.5e-06	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.41e-07	6.46e-06	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	5.4e-07	6.45e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—EGFR—type 2 diabetes mellitus	5.39e-07	6.44e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—EGFR—type 2 diabetes mellitus	5.39e-07	6.44e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.37e-07	6.42e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.36e-07	6.4e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.35e-07	6.39e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.35e-07	6.39e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.33e-07	6.37e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	5.32e-07	6.35e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.31e-07	6.34e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.29e-07	6.32e-06	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.28e-07	6.31e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	5.27e-07	6.29e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.25e-07	6.27e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.24e-07	6.26e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.24e-07	6.25e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.22e-07	6.24e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.22e-07	6.23e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.21e-07	6.22e-06	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.21e-07	6.22e-06	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.21e-07	6.22e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.2e-07	6.2e-06	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.18e-07	6.19e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.18e-07	6.18e-06	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.16e-07	6.16e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.14e-07	6.14e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.14e-07	6.14e-06	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	5.14e-07	6.14e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.13e-07	6.13e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.13e-07	6.12e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.11e-07	6.11e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.11e-07	6.1e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.08e-07	6.07e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.08e-07	6.06e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	5.06e-07	6.05e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.02e-07	6e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.99e-07	5.96e-06	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.98e-07	5.95e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	4.97e-07	5.93e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.94e-07	5.9e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.94e-07	5.9e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.91e-07	5.86e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.91e-07	5.86e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.88e-07	5.83e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.87e-07	5.82e-06	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.86e-07	5.81e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.83e-07	5.77e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.82e-07	5.75e-06	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.8e-07	5.73e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.79e-07	5.72e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.78e-07	5.71e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.78e-07	5.7e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.78e-07	5.7e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.77e-07	5.69e-06	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.76e-07	5.68e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.75e-07	5.68e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.75e-07	5.67e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.73e-07	5.64e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.71e-07	5.62e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.7e-07	5.61e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.7e-07	5.61e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.69e-07	5.6e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.69e-07	5.6e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.68e-07	5.59e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.68e-07	5.58e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.67e-07	5.58e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.67e-07	5.58e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.66e-07	5.56e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IL6—type 2 diabetes mellitus	4.64e-07	5.54e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.62e-07	5.52e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.62e-07	5.52e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.62e-07	5.51e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.6e-07	5.5e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.58e-07	5.47e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	4.55e-07	5.44e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.53e-07	5.41e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.53e-07	5.41e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.5e-07	5.38e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IL6—type 2 diabetes mellitus	4.49e-07	5.36e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IL6—type 2 diabetes mellitus	4.49e-07	5.36e-06	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.49e-07	5.36e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.49e-07	5.36e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.45e-07	5.32e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.43e-07	5.29e-06	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.43e-07	5.29e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.36e-07	5.21e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.35e-07	5.2e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	4.35e-07	5.2e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.34e-07	5.18e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.31e-07	5.14e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.31e-07	5.14e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—IL6—type 2 diabetes mellitus	4.28e-07	5.11e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—AKT1—type 2 diabetes mellitus	4.28e-07	5.11e-06	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	4.28e-07	5.11e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.28e-07	5.11e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.19e-07	5.01e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.19e-07	5.01e-06	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.18e-07	4.99e-06	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	4.16e-07	4.97e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—IL6—type 2 diabetes mellitus	4.14e-07	4.95e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—IL6—type 2 diabetes mellitus	4.14e-07	4.95e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—AKT1—type 2 diabetes mellitus	4.14e-07	4.94e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—AKT1—type 2 diabetes mellitus	4.14e-07	4.94e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.98e-07	4.76e-06	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.98e-07	4.75e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.98e-07	4.75e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	3.95e-07	4.72e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—AKT1—type 2 diabetes mellitus	3.95e-07	4.72e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.91e-07	4.67e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.9e-07	4.66e-06	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.86e-07	4.61e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.85e-07	4.6e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.85e-07	4.6e-06	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.84e-07	4.58e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.83e-07	4.58e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—AKT1—type 2 diabetes mellitus	3.82e-07	4.56e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—AKT1—type 2 diabetes mellitus	3.82e-07	4.56e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.77e-07	4.51e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.77e-07	4.51e-06	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.67e-07	4.39e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.67e-07	4.38e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	3.63e-07	4.33e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.61e-07	4.31e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.6e-07	4.3e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.59e-07	4.29e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	3.58e-07	4.28e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.55e-07	4.24e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.54e-07	4.22e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.51e-07	4.19e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.39e-07	4.04e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.36e-07	4.01e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.36e-07	4.01e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.33e-07	3.98e-06	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	3.33e-07	3.98e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.33e-07	3.97e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.31e-07	3.96e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	3.31e-07	3.95e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.3e-07	3.95e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.29e-07	3.92e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.27e-07	3.91e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.26e-07	3.9e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	3.2e-07	3.82e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	3.2e-07	3.82e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.07e-07	3.67e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.03e-07	3.62e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	3e-07	3.58e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.9e-07	3.46e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.9e-07	3.46e-06	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—AKT1—type 2 diabetes mellitus	2.86e-07	3.42e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.77e-07	3.3e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.68e-07	3.2e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.68e-07	3.2e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.51e-07	2.99e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.36e-07	2.82e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2e-07	2.39e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.54e-07	1.84e-06	CbGpPWpGaD
